Daniela Verrigni

1.4k total citations
25 papers, 715 citations indexed

About

Daniela Verrigni is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Daniela Verrigni has authored 25 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Clinical Biochemistry and 3 papers in Physiology. Recurrent topics in Daniela Verrigni's work include Mitochondrial Function and Pathology (18 papers), ATP Synthase and ATPases Research (11 papers) and Metabolism and Genetic Disorders (11 papers). Daniela Verrigni is often cited by papers focused on Mitochondrial Function and Pathology (18 papers), ATP Synthase and ATPases Research (11 papers) and Metabolism and Genetic Disorders (11 papers). Daniela Verrigni collaborates with scholars based in Italy, United Kingdom and United States. Daniela Verrigni's co-authors include Enrico Bertini, Rosalba Carrozzo, Teresa Rizza, Alessandra Torraco, Diego Martinelli, Carlo Dionisi‐Vici, Michela Di Nottia, Fiorella Piemonte, Daniele Ghezzi and Daria Diodato and has published in prestigious journals such as Cell Metabolism, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Daniela Verrigni

24 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Verrigni Italy 17 484 210 102 74 59 25 715
Florence Habarou France 16 372 0.8× 250 1.2× 72 0.7× 45 0.6× 46 0.8× 23 727
François Eyskens Belgium 17 462 1.0× 331 1.6× 158 1.5× 52 0.7× 17 0.3× 38 779
Emma Footitt United Kingdom 17 387 0.8× 412 2.0× 92 0.9× 16 0.2× 40 0.7× 29 735
Cheng-Heng Kao Taiwan 11 517 1.1× 47 0.2× 119 1.2× 109 1.5× 16 0.3× 12 758
Noman Kadhom France 10 1.0k 2.1× 453 2.2× 79 0.8× 16 0.2× 18 0.3× 10 1.2k
Mauro Scarpelli Italy 17 535 1.1× 312 1.5× 179 1.8× 5 0.1× 94 1.6× 34 796
María Antònia Vilaseca Spain 20 639 1.3× 652 3.1× 269 2.6× 9 0.1× 43 0.7× 45 1.1k
H. D. Bakker Netherlands 14 267 0.6× 354 1.7× 175 1.7× 13 0.2× 29 0.5× 28 556
Peng Liao China 7 279 0.6× 53 0.3× 108 1.1× 9 0.1× 19 0.3× 14 560
A. E. M. Stroomer Netherlands 10 271 0.6× 185 0.9× 61 0.6× 5 0.1× 22 0.4× 13 445

Countries citing papers authored by Daniela Verrigni

Since Specialization
Citations

This map shows the geographic impact of Daniela Verrigni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Verrigni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Verrigni more than expected).

Fields of papers citing papers by Daniela Verrigni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Verrigni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Verrigni. The network helps show where Daniela Verrigni may publish in the future.

Co-authorship network of co-authors of Daniela Verrigni

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Verrigni. A scholar is included among the top collaborators of Daniela Verrigni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Verrigni. Daniela Verrigni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piceci‐Sparascio, Francesca, Fabrizia Stregapede, Antonio Terracciano, et al.. (2025). MTSS2‐Related Disorder: Refining the Phenotype in Four New Cases and Literature Review. American Journal of Medical Genetics Part A. 197(6). e64010–e64010.
2.
Berti, Beatrice, Daniela Verrigni, Alessia Nasca, et al.. (2024). De Novo DNM1L Mutation in a Patient with Encephalopathy, Cardiomyopathy and Fatal Non-Epileptic Paroxysmal Refractory Vomiting. International Journal of Molecular Sciences. 25(14). 7782–7782. 2 indexed citations
3.
Primiano, Guido, Alessandra Torraco, Daniela Verrigni, et al.. (2022). Novel TOP3A Variant Associated With Mitochondrial Disease. Neurology Genetics. 8(4). e200007–e200007. 11 indexed citations
4.
Nottia, Michela Di, Maria Marchese, Daniela Verrigni, et al.. (2020). A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly. Neurobiology of Disease. 141. 104880–104880. 32 indexed citations
5.
Castiglioni, Claudia, Fabiana Fattori, Bjarne Udd, et al.. (2018). Neuromyopathy with congenital cataracts and glaucoma: a distinct syndrome caused by POLG variants. European Journal of Human Genetics. 26(3). 367–373. 2 indexed citations
6.
Catania, Alessia, Anna Ardissone, Daniela Verrigni, et al.. (2018). Compound heterozygous missense and deep intronic variants in NDUFAF6 unraveled by exome sequencing and mRNA analysis. Journal of Human Genetics. 63(5). 563–568. 16 indexed citations
7.
Torraco, Alessandra, Oliver Stehling, Ralf Rösser, et al.. (2018). ISCA1 mutation in a patient with infantile-onset leukodystrophy causes defects in mitochondrial [4Fe–4S] proteins. Human Molecular Genetics. 27(15). 2739–2754. 29 indexed citations
8.
Nottia, Michela Di, Arianna Montanari, Daniela Verrigni, et al.. (2017). Novel mutation in mitochondrial Elongation Factor EF-Tu associated to dysplastic leukoencephalopathy and defective mitochondrial DNA translation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(4). 961–967. 18 indexed citations
9.
Torraco, Alessandra, Anna Ardissone, Federica Invernizzi, et al.. (2016). Novel mutations in IBA57 are associated with leukodystrophy and variable clinical phenotypes. Journal of Neurology. 264(1). 102–111. 34 indexed citations
10.
Castiglioni, Claudia, Daniela Verrigni, Karin Álvarez, et al.. (2015). Pyruvate dehydrogenase deficiency presenting as isolated paroxysmal exercise induced dystonia successfully reversed with thiamine supplementation. Case report and mini-review. European Journal of Paediatric Neurology. 19(5). 497–503. 39 indexed citations
11.
Diodato, Daria, Giorgio Tasca, Daniela Verrigni, et al.. (2015). A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease. European Journal of Human Genetics. 24(3). 463–466. 53 indexed citations
12.
Maio, Nunziata, Daniele Ghezzi, Daniela Verrigni, et al.. (2015). Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB. Cell Metabolism. 23(2). 292–302. 84 indexed citations
13.
Catteruccia, Michela, Daniela Verrigni, Diego Martinelli, et al.. (2014). Persistent pulmonary arterial hypertension in the newborn (PPHN): A frequent manifestation of TMEM70 defective patients. Molecular Genetics and Metabolism. 111(3). 353–359. 21 indexed citations
14.
Carrozzo, Rosalba, Alessandra Torraco, Giuseppe Fiermonte, et al.. (2014). Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2. Mitochondrion. 18. 49–57. 45 indexed citations
15.
Boenzi, Sara, Federica Deodato, Roberta Taurisano, et al.. (2014). A new simple and rapid LC–ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann–Pick type C disease. Clinica Chimica Acta. 437. 93–100. 57 indexed citations
16.
Torraco, Alessandra, Rosalba Carrozzo, Fiorella Piemonte, et al.. (2014). Effects of levosimendan on mitochondrial function in patients with septic shock: A randomized trial. Biochimie. 102. 166–173. 41 indexed citations
17.
D’Amico, Adele, Enrico Bertini, Andrea Dardis, et al.. (2013). Efficacy of Miglustat in Niemann–Pick C disease: A single centre experience. Molecular Genetics and Metabolism. 110(3). 329–335. 16 indexed citations
18.
Nogueira, Célia, José Barros, María José Sá, et al.. (2013). Novel TTC19 mutation in a family with severe psychiatric manifestations and complex III deficiency. Neurogenetics. 14(2). 153–160. 35 indexed citations
19.
Torraco, Alessandra, Daniela Verrigni, Teresa Rizza, et al.. (2012). TMEM70: a mutational hot spot in nuclear ATP synthase deficiency with a pivotal role in complex V biogenesis. Neurogenetics. 13(4). 375–386. 22 indexed citations
20.
Bianchi, Marzia, Teresa Rizza, Daniela Verrigni, et al.. (2011). Novel large-range mitochondrial DNA deletions and fatal multisystemic disorder with prominent hepatopathy. Biochemical and Biophysical Research Communications. 415(2). 300–304. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florence Habarou Breakdown of academic impact, for papers by François Eyskens Breakdown of academic impact, for papers by Emma Footitt Breakdown of academic impact, for papers by Cheng-Heng Kao Breakdown of academic impact, for papers by Noman Kadhom Breakdown of academic impact, for papers by Mauro Scarpelli Breakdown of academic impact, for papers by María Antònia Vilaseca Breakdown of academic impact, for papers by H. D. Bakker Breakdown of academic impact, for papers by Peng Liao Breakdown of academic impact, for papers by A. E. M. Stroomer
Rankless by CCL
2026